Abstract
From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have